Thank you to all who joined us live Primary Care Pulse on August 4, 2020. If you were not able to join us live, the sessions have been recorded and are available below.

Upcoming Virtual Conferences
Join your clinician colleagues and expert faculty as they present the latest clinical insights and guidelines during a variety of upcoming virtual education opportunities, including Primary Care Pulse and PrimaryCareNOW.

Agenda

  CME/CE Accredited Session

Non CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

12–12:30pm ET

Infectious Disease

 


In the fifteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will revisit the data on chloroquine and hydroxychloroquine in the treatment of COVID-19 and will discuss the data on the effectiveness of hydroxychloroquine in post-exposure prophylaxis. Faculty will also review the recent data on proton pump inhibitors (PPI) and histamine2-receptor antagonists (H2RA) as they relate to COVID-19 risk, giving you the most current information on how to manage your patients taking these medications.

Ty J. Gluckman, MD, FACC, FAHA 

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Charles Vega, MD, FAAFP 

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine Irvine, CA

12:45–1:15pm ET

Cardiology

Update on Atrial Fibrillation

Ty J. Gluckman, MD, FACC, FAHA


 

Atrial fibrillation is the most common sustained cardiac arrhythmia in clinical practice and conveys a 4- to 5-fold increased risk of stroke; yet, it often goes undiagnosed and untreated in a primary care setting. In the program, Dr. Ty Gluckman discusses how to recognize patients at high risk for AF, evaluate patients newly diagnosed with AF, assess risk of bleeding and thromboembolism, and apply evidence-based recommendations to reduce thromboembolic risk.

Ty J. Gluckman, MD, FACC, FAHA 

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR


CME/CE Faculty

Ty J. Gluckman, MD, FACC, FAHA
Ty J. Gluckman, MD,
FACC, FAHA
Charles Vega, MD, FAAFP 
Charles Vega, MD, FAAFP